Estimation of metabolic factors related to insulin resistance and metabolic syndrome in young people

References

• Nanditha A, Ma RC, Ramachandran A, et al. Diabetes in Asia and the Pacific: implications for the global epidemic. Diabetes Care. 2016;39:472–485.
   PubMed Web of Science ®Google Scholar
• Madeira FB, Silva AA, Veloso HF, et al. Normal weight obesity is associated with metabolic syndrome and insulin resistance in young adults from a middle-income country. PLoS One. 2013;8:e60673.
   PubMed Web of Science ®Google Scholar
• Defronzo RA. Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 2009;58:773–795.
   PubMed Web of Science ®Google Scholar
• Bergmann K, Sypniewska G. Diabetes as a complication of adipose tissue dysfunction. Is there a role for potential new biomarkers? Clin Chem Lab Med. 2013;51:177–185.
   PubMed Web of Science ®Google Scholar
• Muoio DM, Neufer PD. Lipid-induced mitochondrial stress and insulin action in muscle. Cell Metab. 2012;15:595–605.
   PubMed Web of Science ®Google Scholar
• Pacholczyk M, Ferenc T, Kowalski J. Zespół metaboliczny. Część I: Defi nicje i kryteria rozpoznawania zespołu metabolicznego. Epidemiologia oraz związek z ryzykiem chorób sercowo-naczyniowych i cukrzycy typu 2 [The metabolic syndrome. Part I: definitions and diagnostic criteria for its identification. Epidemiology and relationship with cardiovascular and type 2 diabetes risk]. Postepy Hig Med Dosw. 2008;62:530–542. Polish.
   Web of Science ®Google Scholar
• Alberti KGMM, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International atherosclerosis society; And international association for the study of obesity. Circulation. 2009;120:1640–1645.
   PubMed Web of Science ®Google Scholar
• Linder K, Springer F, Machann J, et al. Relationships of body composition and liver fat content with insulin resistance in obesity-matched adolescents and adults. Obesity (Silver Spring). 2014;22:1325–1331.
   PubMed Web of Science ®Google Scholar
• Hu FB. Globalization of Diabetes: The role of diet, lifestyle, and genes. Diabetes Care. 2011;34:1249–1257.
   PubMed Web of Science ®Google Scholar
• Płaczkowska S, Pawlik-Sobecka L, Kokot I, Piwowar A. Częstość występowania złożonych zaburzeń metabolicznych wśród osób młodych – badanie wstępne [Incidence of complex metabolic disorders among young people-preliminary report]. Pol Merkur Lekarski. 2014;37:269–273. Polish.
   PubMedGoogle Scholar
• Tam CS, Xie W, Johnson WD, et al. Defining insulin resistance from hyperinsulinemic-euglycemic clamps. Diabetes Care. 2012;35:1605–1610.
   PubMed Web of Science ®Google Scholar
• Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27:1487–1495.
   PubMed Web of Science ®Google Scholar
• Płaczkowska S, Pawlik-Sobecka L, Kokot I, Piwowar A. Analiza częstości występowania insulinooporności u osób młodych w oparciu o wybrane kryteria diagnostyczne – badanie wstępne [Incidence of insulin resistance according to specified diagnostic criteria – a preliminary report]. Hygeia Public Health. 2014;49:851–856.
   Google Scholar
• Guidelines on the management of diabetic patients. A position of Diabetes Poland. Clin Diabet 2017;6(Suppl. A):A1–A80.
   Google Scholar
• University of Oxford. Diabetes trail unit. [Internet]. OCDM; [cited 23 September 2017]. Available from: http://www.dtu.ox.ac.uk/homacalculator/
   Google Scholar
• Masafumi Matsuda. [Internet]. [cited 23 September 2017]. Available from: http://mmatsuda.diabetes-smc.jp/MIndexsi.html
   Google Scholar
• Jackson DA. Stopping Rules in Principal Components Analysis: A Comparison of Heuristical and Statistical Approaches. Ecology. 1993;74:2204–2214.
   Web of Science ®Google Scholar
• Moore JX, Chaudhary N, Akinyemiju T. Metabolic syndrome prevalence by race/ethnicity and sex in the United States, National Health and Nutrition Examination Survey, 1988-2012. Prev Chronic Dis. 2017;14:E24.
   Web of Science ®Google Scholar
• Suliga E, Koziel D, Gluszek S. Prevalence of metabolic syndrome in normal weight individuals. Ann Agric Environ Med. 2016;23:631–635.
   PubMed Web of Science ®Google Scholar
• Ilow R, Regulska-Ilow B, Rozanska D, Kowalisko A, Biernat J. Prevalence of metabolic syndrome among 40- and 50-year-old inhabitants of Wroclaw, Poland. Ann Agric Environ Med. 2012;19:551–556.
   PubMed Web of Science ®Google Scholar
• Li R, Li W, Lun Z, et al. Prevalence of metabolic syndrome in mainland china: a meta-analysis of published studies. BMC Public Health. 2016;16:296.
   PubMed Web of Science ®Google Scholar
• Mattsson N, Ronnemaa T, Juonala M, et al. The prevalence of the metabolic syndrome in young adults. The Cardiovascular Risk in Young Finns Study. J Intern Med. 2007;261:159–169.
   PubMed Web of Science ®Google Scholar
• Broda G, Szcześniewska D, Rywik S. Częstość występowania zespołu metabolicznego w populacji osób dorosłych Warszawy [The prevalence of metabolic syndrome in the adult population of Warsaw]. Medycyna Metab. 2003;7:225–229. Polish.
   Google Scholar
• Płaczkowska S, Pawlik-Sobecka L, Kokot I, et al. Discrepancies in occurrence of metabolic disturbances related to gender among young people. FMPCR. 2017;19:387–392.
   Google Scholar
• Gray RS, Fabsitz RR, Cowan LD, et al. Risk factor clustering in the insulin resistance syndrome. The Strong Heart Study. Am J Epidemiol. 1998;148:869–878.
   PubMed Web of Science ®Google Scholar
• Kassi E, Pervanidou P, Kaltsas G, et al. Metabolic syndrome: definitions and controversies. BMC Med. 2011;9:48.
   PubMed Web of Science ®Google Scholar
• Badaruddoza, Kumar R, Kaur M. Principal component analysis of cardiovascular risk traits in three generations cohort among Indian Punjabi population. J Adv Res. 2015;6:739–746.
   PubMed Web of Science ®Google Scholar
• Panazzolo DG, Sicuro FL, Clapauch R, et al. Obesity, metabolic syndrome, impaired fasting glucose, and microvascular dysfunction: a principal component analysis approach. BMC Cardiovasc Disord. 2012;12:102.
   PubMed Web of Science ®Google Scholar
• Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937–952.
   PubMed Web of Science ®Google Scholar
• Mamcarz A, Podolec P, Kopeć G, et al. Konsensus Grupy Roboczej PFP dotyczący zespołu metabolicznego [Consensus of the PFP Working Group on Metabolic Syndrome]. Forum Profilaktyki. 2009;14:1.
   Google Scholar
• Gierach M, Gierach J, Ewertowska M, et al. Correlation between body mass index and waist circumference in patients with metabolic syndrome. ISRN Endocrinol. 2014;2014:Article ID 514586.
   PubMedGoogle Scholar
• Yamada C, Moriyama K, Takahashi E. Association between insulin resistance and metabolic syndrome risk factors in Japanese. J Diabetes Investig. 2012;3:185–90.
   PubMed Web of Science ®Google Scholar
• Kokot I, Pawlik-Sobecka L, Płaczkowska S, et al. The relationship between total body fat and distribution of body fat mass and markers of insulin resistance in young women with normal weight - a pilot study. Clin Diabetol. 2016;5:41–48.
   Google Scholar
• Nolan JJ, Faerch K. Estimating insulin sensitivity and beta cell function: perspectives from the modern pandemics of obesity and type 2 diabetes. Diabetologia. 2012;55:2863–2867.
   PubMed Web of Science ®Google Scholar
• Geloneze B, Vasques AC, Stabe CF, et al. HOMA1-IR and HOMA2-IR indexes in identifying insulin resistance and metabolic syndrome: Brazilian Metabolic Syndrome Study (BRAMS). Arq Bras Endocrinol Metab. 2009;53:281–287.
   PubMed Web of Science ®Google Scholar
• Szurkowska M, Szafraniec K, Gilis-Januszewska A, Szybiński Z, Huszno B. Wskaźniki insulinooporności w badaniu populacyjnym i ich wartość predykcyjna w określeniu zespołu metabolicznego [Insulin resistance indices in population-based study and their predictive value in defining metabolic syndrome]. Przegl Epidemiol. 2005;59:743–751.
   PubMedGoogle Scholar
• Yamada C, Moriyama K, Takahashi E. Optimal cut-off point for homeostasis model assessment of insulin resistance to discriminate metabolic syndrome in non-diabetic Japanese subjects. J Diabetes Investig. 2012;3:384–387.
   PubMed Web of Science ®Google Scholar